Latest Industry News & Trends

Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with companies executive. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.

Recently Added News

9/23/2022
BreakingEuropePharmaRegulationRetina
Roche’s Vabysmo Gains EU Approval for Wet AMD, DME
Roche’s Vabysmo Gains EU Approval for Wet AMD, DME

Swiss drugmaker Roche announced Sept. 19 that the European Commission had approved Vabysmo (faricimab) for the treatment of wet age-related macular degeneration (AMD) and visual impairment due to d...

9/23/2022
BiosimilarsBreakingRetina
Coherus Plans to Launch Lucentis Biosimilar Cimerli in US in October 2022
Coherus Plans to Launch Lucentis Biosimilar Cimerli in US in October 2022

Coherus BioSciences announced Sept. 19 that its ranibizumab biosimilar, Cimerli, will be commercially available in the US beginning Oct. 3, 2022. Cimerli (ranibizumab-eqrn) was approved by the US F...

9/23/2022
BreakingDry EyePharmaRegulation
Akorn to Pay $7.9 Million to Resolve Case Involving False Medicare Claims
Akorn to Pay $7.9 Million to Resolve Case Involving False Medicare Claims

Pharmaceutical company Akorn has agreed to pay $7.9 million to resolve allegations that it caused the submission of false claims to Medicare Part D for three generic drugs, including an ophthalmic ...

9/23/2022
BreakingSurgical
Court Rules in Favor of UnitedHealth Over Facility Fees for Office-Based Surgery
Court Rules in Favor of UnitedHealth Over Facility Fees for Office-Based Surgery

A federal court ruled Sept. 14 that UnitedHealth is not required to pay facility fees for office-based surgery. Plaintiffs were a group of doctors from New York. They claimed that UnitedHealth rece...

9/23/2022
BreakingDealsDiagnosticDry Eye
Verséa Ophthalmics Gains Global License to Axim’s Dry Eye Diagnostics
Verséa Ophthalmics Gains Global License to Axim’s Dry Eye Diagnostics

Axim Biotechnologies announced Sept. 19 that it had signed an exclusive global commercial partnership deal with Verséa Ophthalmics, a division of Verséa Holdings. Verséa gains exclusive commercial ...

9/23/2022
BreakingChinaClinical TrialRetina
Chinese Regulators Approve Phase III Trial of Belite Bio’s Oral Stargardt Candidate
Chinese Regulators Approve Phase III Trial of Belite Bio’s Oral Stargardt Candidate

Belite Bio announced Sept. 16 that the National Medical Products Administration (NMPA) of China had approved a Phase III trial of LBS-008 (tinlarebant), Belite’s oral treatment candidate for Starga...

9/23/2022
BreakingIndustryRetina
Johnson & Johnson Opens New R&D Hub in Bay Area; Retinal Program Part of Broad Focus
Johnson & Johnson Opens New R&D Hub in Bay Area; Retinal Program Part of Broad Focus

Johnson & Johnson, of New Brunswick, New Jersey, reported Sept. 20 that it had opened a new 200 thousand-square-foot R&D facility in the San Francisco area that will integrate drug discovery, data ...

9/23/2022
BreakingIndustryMicroscopes
Haag-Streit Transfers Microscope Production to New Site in Switzerland
Haag-Streit Transfers Microscope Production to New Site in Switzerland

Swiss company Haag-Streit announced Aug. 25 the opening of a new state-of-the-art surgical microscope production site in Aesch, Switzerland. The company said it has moved production of its surgical...

9/23/2022
BreakingCornealSurgical
€1 Million Vision Award Goes to Two Leaders in Research, Treatment of Corneal Disease
€1 Million Vision Award Goes to Two Leaders in Research, Treatment of Corneal Disease

Two physician-scientists who are leaders in the research and treatment of corneal disease have been honored with a €1 million vision award by Portugal’s Champalimaud Foundation, the group announced...

9/23/2022
BreakingRefractiveSurgical
Team Wins 2022 Golden Goose Award for Contributions to Bladeless LASIK
Team Wins 2022 Golden Goose Award for Contributions to Bladeless LASIK

Five pioneers in the use of femtosecond lasers for ophthalmology have been honored with the Golden Goose Award from the American Association for the Advancement of Science (AAAS), the world’s large...

9/22/2022
EarningsNewsletterRevenue
Ophthalmic Company Revenue Flat in Second Quarter of 2022
Ophthalmic Company Revenue  Flat in Second Quarter of 2022

Ophthalmic manufacturer revenue in Q2-2022 totaled $11.1 billion. Four public companies reported record-high earnings in Q2-2022 compared with the past three years, while four public companies had ...

9/22/2022
CataractGlaucomaIOLNewsletterRetina
US Eye Surgeons Report 7.1 Percent Increase in Q2-2022 Procedure Volume
US Eye Surgeons Report 7.1 Percent Increase in Q2-2022 Procedure Volume

US ophthalmologists reported that ophthalmic procedures increased 7.1 percent in Q2-2022 compared with the same quarter in 2021, according to Market Scope’s latest survey. Year-over-year performanc...

Past News Stories

9/22/2022
NewsletterRetina
European Retina Specialists Aim to Achieve ‘Impossible’ Goals
European Retina Specialists Aim to Achieve ‘Impossible’ Goals

The world’s largest retina meeting led off with a discussion of how to achieve “impossible” goals before delving into policy discussions and debates over treatment philosophies. Topics discussed ac...

9/22/2022
CataractNewsletterSingle-Use
Single-Use Ophthalmic Device Market Continues to Grow, Despite Headwinds
Single-Use Ophthalmic Device Market Continues to Grow, Despite Headwinds

Sales of single-use ophthalmic surgical devices continue to show modest growth despite a reduction in ophthalmic surgery due the COVID-19 pandemic and recent concerns over the environmental impact ...

9/22/2022
GlaucomaNewsletter
Glaukos Reports Positive Topline Phase III Data for iDose TR Implant
Glaukos Reports Positive Topline Phase III Data for iDose TR Implant

Glaukos reported on Sept. 7 positive topline data for both Phase III pivotal trials of its iDose TR sustained-release travaprost implant for glaucoma. Both the fast- and slow-release iDose TR treat...

9/22/2022
DigitalNewsletterRefractive
Visibly, Formerly Opternative, Gains First US FDA Clearance for an Online Vision Test
Visibly, Formerly Opternative, Gains First US FDA Clearance for an Online Vision Test

Visibly, of Chicago, announced Aug. 16 that the US FDA had granted 510(k) clearance to its Visibly Digital Acuity Product. It becomes the first FDA-cleared online visual acuity test on the US marke...

9/22/2022
NewsletterScope of Practice
California Legislature Passes Bill to Expand Scope of Practice for ODs
California Legislature Passes Bill to Expand Scope of Practice for ODs

The California Legislature has passed a bill to allow optometrists in the state to perform several laser procedures on the eye. The bill—AB 2236: “Optometry: Certification to Perform Advanced Proce...

9/22/2022
CataractDiagnosticGlaucomaNewsletterRefractiveRegulationRetinaSurgical
Select US FDA Approvals and Clearances in August 2022
Select US FDA Approvals and Clearances in August 2022

The US FDA granted six clearances through the ophthalmic device division using the 510(k) pathway in August 2022, according to the agency’s database. Carl Zeiss Meditec received clearance for multi...

9/22/2022
NewsletterRegulation
US FDA Waives Fee for Ocuphire’s NDA for Reversal of Mydriasis Candidate Nyxol
US FDA Waives Fee for Ocuphire’s NDA for Reversal of Mydriasis Candidate Nyxol

Ocuphire Pharma announced Sept. 12 that the US FDA had granted a small business waiver of the Prescription Drug User Fee Act (PDUFA) fee of $3.1 million for the company’s new drug application (NDA)...

9/22/2022
NewsletterRegulationStudy
White House Makes Publicly Funded Research Open Access
White House Makes Publicly Funded Research Open Access

The Biden administration on Aug. 25 directed federal agencies to make published research from studies funded with taxpayer dollars available immediately for free after it is published. The White Ho...

9/22/2022
DealsMicroscopesNewsletterSingle-Use
Bausch + Lomb Announces Collaborations in Ocular Dyes, Digital Microscopy
Bausch + Lomb Announces Collaborations  in Ocular Dyes, Digital Microscopy

Bausch + Lomb is collaborating with two European companies to expand its ophthalmic portfolio. The Canada-based Bausch Health subsidiary reported on Sept. 1 that it had become the exclusive global ...

9/22/2022
Dry EyeIndustryNewsletter
Trukera Medical Launches New ScoutPro Osmolarity System
Trukera Medical Launches New ScoutPro Osmolarity System

Trukera Medical, formerly TearLab, on Sept. 12 unveiled the ScoutPro Osmolarity System, the first product under the company’s new brand. The ScoutPro is the first portable osmometer in the US, Truk...

9/22/2022
DiagnosticDry EyeFundingGene TherapyGlaucomaNewsletterRetina
Viridian Leads Latest Ophthalmic Fundraising with $270 Million Public Offering
Viridian Leads Latest Ophthalmic Fundraising with $270 Million Public Offering

Viridian Therapeutics led recent fundraising efforts by ophthalmic companies with $270 million in an underwritten public offering to support its candidates for thyroid eye disease. Funding for the ...

9/22/2022
CataractMeetingNewsletterSurgical
ESCRS Meeting Sees Attendance Soar, While Focus Turns to Reducing Waste
ESCRS Meeting Sees Attendance Soar, While Focus Turns to Reducing Waste

The 2022 congress of the European Society of Cataract and Refractive Surgeons (ESCRS), held Sept. 16-20 in Milan, Italy, marked the first real return of international meetings since 2020, when the ...

Want to Read the Full Article?

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more